Drug Profile
A 315677
Alternative Names: A-315677Latest Information Update: 30 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antivirals
- Mechanism of Action Neuraminidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 18 Sep 2006 Discontinued - Preclinical for Influenza virus infections in USA (unspecified route)
- 12 Feb 2002 New profile
- 12 Feb 2002 Preclinical development for Influenza virus infections in USA (Unknown route)